Pfizer
Fortune Rankings
- Updated:1/31/24
- Country:U.S.
- Headquarters:New York City
- Industry:Pharmaceuticals
- CEO:Albert Bourla
- Website:https://www.pfizer.com
- Ticker:PFE
- Company type:Public
- Revenues ($M):$58,496
- Profits ($M):$2,119
- Market value ($M):$156,529
- Number of employees:88,000
Figures are for fiscal year ended Dec. 31, 2023. Market value as of March 18, 2024. Sources: SEC filings; S&P Global.
- $ Millions% change
- Revenues ($M):$100,33023.4%
- Profits ($M):$31,37242.7%
- Assets ($M):$197,205-
- Total Stockholder Equity ($M):$95,661-
- Profit as % of Revenues:31.3%
- Profits as % of Assets:15.9%
- Profits as % of Stockholder Equity:32.8%
- Earnings Per Share ($):5.47
- EPS % Change (from 2021):42.1%
- EPS % Change (5 year annual rate):9.2%
- EPS % Change (10 year annual rate):10.9%
- Total Return to Investors (2022):-10.3%
- Total Return to Investors (5 year, annualized):12.3%
- Total Return to Investors (10 year, annualized):11.9%
- Revenue 3 Yr Growth Rank:18
- Revenue 3 Yr Annual Growth Rate:48%
- EPS 3 Yr Growth Rank:91
- EPS 3 Yr Annual Growth Rate:40%
- Total Return 3 Yr Rank:94
- Total Return 3 Yr Annual Rate (Through June 30, 2023):9%
- Beat S&P 500 3 Yr Return (14.6%):no
- Years on List:1
- Sector:Health Care
- Sector:Natural resources
- Industry:Pharmaceuticals
- Current All-Star Rank:20
- Previous All-Star Rank:8
- Industry Rank:-
- Previous Industry Rank:-
- Overall Score:-
- Innovation:-
- People Management:-
- Use of Corporate Assets:-
- Social Responsibility:-
- Quality of Management:-
- Financial Soundness:-
- Long-Term Investment Value:-
- Quality of Products/Services:-
- Global Competitiveness:-
- Sector:Health Care
- Culture rank:140
- Process rank:40
- Product rank:94